The first results of the small-scale human trial of the vaccine
developed by the Gamaleya Institute in Moscow have shown it to be safe to use, according to a report released Sunday by RIA.
MOSCOW Russia (Agencies) – A Russian institute developing one of the country’s potential coronavirus vaccines is waiting for the final stage of testing on a small group of the general public in mid-August, the RIA news agency said Monday, citing the institute’s director.
Globally, only two of the 19 experimental COVID-19 vaccines for human testing are in Phase III trials – one by Sinopharm of China and one by AstraZeneca and Oxford University. Sinovac Biotech in China will become the third later this month.
The first results from the small-scale human trial of the vaccine developed by the Gamaleya Institute in Moscow have shown it to be safe for use, according to a report released Sunday by RIA.
“I hope that, around August 14-15, the small amount of vaccine we can produce will enter public circulation,” said Alexander Ginsburg, director of the institute.
That will be equivalent to a Phase III trial because the people who receive the vaccine will remain under supervision, RIA reported, citing Ginsburg.
Phase I and Phase II trials typically review the safety of a drug before it enters Phase III trials that test its effectiveness in a larger group of volunteers.
The Gamaleya Institute’s human trials of the vaccine began June 18, when nine volunteers received one dose, and nine others tested the possibility of a booster dose.
The group experienced no significant side effects and should be discharged from the hospital by Wednesday, RIA reported Sunday, citing the director of Sechenov University in Moscow, where the trial was conducted.
“The data currently available … show that volunteers have developed an immune response to the coronavirus vaccine,” said the Defense Ministry, which is involved in the trials, RIA said Monday. Another 20 volunteers received the vaccine at a military hospital on June 23.
more recommended stories
Influenza season ends with six deaths in Yucatan
The 2021-2022 seasonal influenza season concluded.
Bull escapes and injures a seven-year-old boy in Espita Yucatán
On Friday May 20th, a bull.
Due to excessively expensive municipal operating licenses, tourists and locals were left without beer in Progreso, Yucatan
After all the Six beer agencies.
Covid-19 in Yucatan: ”The pandemic is not over yet”, expert warns about summer vacations
The gradual rebound in Covid-19 infections.
IMSS Yucatan makes a public recognition to Nursing Staff
The Mexican Institute of Social Security.
Xcaret postpones the 14th edition of the Sacred Maya Journey
The return of the traditional Sacred.
A woman is crushed to death when a tree falls on top of her car on the Mérida-Valladolid highway
A strange accident happened on Thursday,.
With these local flowers, you help prevent the loss of bees in Yucatan
Every May 20, World Bee Day.
US government officials talk about UFOs publicly for the first time in 50 years
Two senior U.S. defense intelligence officials.
The US Embassy to invest 30 million USD in the “South of Mexico Generating Employment and Sustainability” program
In alliance with seven governments from.